Literature DB >> 12379621

Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

J E Salmon1, G Girardi, V M Holers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12379621      PMCID： PMC1766708          DOI： 10.1136/ard.61.suppl_2.ii46

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  46 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 2.  Antiphospholipid antibodies and the protein C pathway.

Authors:  N L Esmon; O Safa; M D Smirnov; C T Esmon
Journal:  J Autoimmun       Date:  2000-09       Impact factor: 7.094

3.  Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss.

Authors:  D W Branch; D J Dudley; M D Mitchell; K A Creighton; T M Abbott; E H Hammond; R A Daynes
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

4.  Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

Authors:  N Di Simone; P L Meroni; N de Papa; E Raschi; D Caliandro; C S De Carolis; M A Khamashta; T Atsumi; G R Hughes; G Balestrieri; A Tincani; P Casali; A Caruso
Journal:  Arthritis Rheum       Date:  2000-01

5.  Immunofluorescent studies of the uteroplacental arteries in normal pregnancy.

Authors:  P E Weir
Journal:  Br J Obstet Gynaecol       Date:  1981-03

6.  Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.

Authors:  S Rehrig; S D Fleming; J Anderson; J M Guthridge; J Rakstang; C E McQueen; V M Holers; G C Tsokos; T Shea-Donohue
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 7.  Complement: a critical test of its biological importance.

Authors:  B Z Schmidt; H R Colten
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

8.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

9.  Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.

Authors:  N S Pattison; L W Chamley; M Birdsall; A M Zanderigo; H S Liddell; J McDougall
Journal:  Am J Obstet Gynecol       Date:  2000-10       Impact factor: 8.661

10.  Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

Authors:  V Michael Holers; Guillermina Girardi; Lian Mo; Joel M Guthridge; Hector Molina; Silvia S Pierangeli; Ricardo Espinola; Liu E Xiaowei; Dailing Mao; Christopher G Vialpando; Jane E Salmon
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307
View more
  28 in total

Review 1.  Is there a microangiopathic antiphospholipid syndrome?

Authors:  Ronald A Asherson; Sylvia S Pierangeli; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

Review 2.  Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

3.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

4.  Maternal and fetal alternative complement pathway activation in early severe preeclampsia.

Authors:  M Camille Hoffman; Kristen K Rumer; Anita Kramer; Anne M Lynch; Virginia D Winn
Journal:  Am J Reprod Immunol       Date:  2013-10-16       Impact factor: 3.886

Review 5.  Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.

Authors:  Mirjana Bećarević
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

6.  C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

Authors:  Al Carrera-Marín; Z Romay-Penabad; E Papalardo; E Reyes-Maldonado; E García-Latorre; G Vargas; T Shilagard; S Pierangeli
Journal:  Lupus       Date:  2012-08-29       Impact factor: 2.911

7.  Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.

Authors:  Danieli Andrade; Patricia B Redecha; Milena Vukelic; Xiaoping Qing; Giorgio Perino; Jane E Salmon; Gloria C Koo
Journal:  Arthritis Rheum       Date:  2011-09

8.  Molecular markers of preterm labor in the choriodecidua.

Authors:  Renu Shankar; Matthew P Johnson; Nicholas A Williamson; Fiona Cullinane; Anthony W Purcell; Eric K Moses; Shaun P Brennecke
Journal:  Reprod Sci       Date:  2009-12-15       Impact factor: 3.060

Review 9.  Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?

Authors:  Sinthiya Punnialingam; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

10.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.